Bioavailability of nanoparticles in nutrient and nutraceutical delivery

Chau, 2007, The development of regulations for food nanotechnology, Trends Food Sci Technol, 18, 269, 10.1016/j.tifs.2007.01.007

Chen, 2006, Nanotechnology in nutraceuticals and functional foods, Food Technol, 60, 30

Chen, 2006, Food protein-based materials as nutraceutical delivery systems, Trends Food Sci Technol, 17, 272, 10.1016/j.tifs.2005.12.011

Sanguansri, 2006, Nanoscale materials development — a food industry perspective, Trends Food Sci Technol, 17, 547, 10.1016/j.tifs.2006.04.010

Garti, 2005, Food goes nano, INFORM, 6, 588

Hamley, 2003, Nanotechnology with soft materials, Angew Chem Int Ed, 42, 1692, 10.1002/anie.200200546

Shimomura, 2001, Bottom-up strategy of materials fabrication: a new trend in nanotechnology of soft materials, Curr Opin Colloid Interface Sci, 6, 11, 10.1016/S1359-0294(00)00081-9

Whitesides, 2002, Self-assembly at all scales, Science, 295, 2418, 10.1126/science.1070821

Inoue, 2007, Application of ascorbic acid 2-glucoside as a solubilizing agent for clarithromycin: solubilization and nanoparticle formation, Int J Pharm, 331, 38, 10.1016/j.ijpharm.2006.09.014

Inkyo, 2006, Experimental investigation of nanoparticle dispersion by beads milling with centrifugal bead separation, J Colloid Interface Sci, 304, 535, 10.1016/j.jcis.2006.09.021

Merisko-Liversidge, 1996, Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs, Pharm Res, 13, 272, 10.1023/A:1016051316815

Horn, 2001, Organic nanoparticles in the aqueous phase — theory, experiment, and use, Angew Chem Int Ed, 40, 4330, 10.1002/1521-3773(20011203)40:23<4330::AID-ANIE4330>3.0.CO;2-W

Peukert, 2005, Control of aggregation in production and handling of nanoparticles, Chem Eng Process, 44, 245, 10.1016/j.cep.2004.02.018

Todaka, 2003, Synthesis of ferrite nanoparticles by mechanochemical processing using a ball mill, Mater Trans, 44, 277, 10.2320/matertrans.44.277

Lomayeva, 2000, The influence of a surfactant on the characteristics of the iron powders obtained by mechanical milling in organic media, Colloids Surf A, 162, 279, 10.1016/S0927-7757(99)00222-8

Liversidge, 1995, Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs, Int J Pharm, 125, 91, 10.1016/0378-5173(95)00122-Y

Liversidge, 1995, Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats, Int J Pharm, 125, 309, 10.1016/0378-5173(95)00148-C

Merisko-Liversidge, 2003, Nanosizing: a formulation approach for poorly-water-soluble compounds, Eur J Pharm Sci, 18, 113, 10.1016/S0928-0987(02)00251-8

Näf, 2005, Converting processes to unfold the potential of nanoparticles, 7412

Olson, 2003, Properties of frozen dairy desserts processed by microfluidization of their mixes, J Dairy Sci, 86, 1157, 10.3168/jds.S0022-0302(03)73698-4

Tunick, 2002, Transmission electron microscopy of Mozzarella cheeses made from microfluidized milk, J Agric Food Chem, 50, 99, 10.1021/jf010633c

Vuillemard, 1991, Recent advances in the large-scale production of lipid vesicles for use in food products: microfluidization, J Microencapsul, 8, 547, 10.3109/02652049109021878

Kosaraju, 2006, Liposomal delivery systems for encapsulation of ferrous sulfate: preparation and characterization, J Liposome Res, 16, 347, 10.1080/08982100600992351

Feijoo, 1997, Effects of Microfluidizer® Technology on Bacillus licheniformis spores in ice cream mix, J Dairy Sci, 80, 2184, 10.3168/jds.S0022-0302(97)76166-6

Liedtke, 2000, Influence of high pressure homogenisation equipment on nanodispersions characteristics, Int J Pharm, 196, 183, 10.1016/S0378-5173(99)00417-2

Chen, 2004, Vitamin E nanoparticle for beverage applications, Chem Eng Res Des, 82, 1432, 10.1205/cerd.82.11.1432.52034

Tan, 2005, β-Carotene nanodispersions: preparation, characterization and stability evaluation, Food Chem, 92, 661, 10.1016/j.foodchem.2004.08.044

Jung, 2001, Particle design using supercritical fluids: literature and patent survey, J Supercrit Fluids, 20, 179, 10.1016/S0896-8446(01)00064-X

Tom, 1991, Particle formation with supercritical fluids. A review, J Aerosol Sci, 22, 555, 10.1016/0021-8502(91)90013-8

Türk, 2002, Micronization of pharmaceutical substances by the Rapid Expansion of Supercritical Solutions (RESS): a promising method to improve bioavailability of poorly soluble pharmaceutical agents, J Supercrit Fluids, 22, 75, 10.1016/S0896-8446(01)00109-7

Hu, 2004, Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs, Drug Dev Ind Pharm, 30, 233, 10.1081/DDC-120030422

Anantachoke, 2006, Fine tuning the production of nanosized β-carotene particles using spinning disk processing, J Am Chem Soc, 128, 13847, 10.1021/ja063545n

Freitas, 1998, Spray-drying of solid lipid nanoparticles (SLN(™)), Eur J Pharm Biopharm, 46, 145, 10.1016/S0939-6411(97)00172-0

Harivardhan, 2005, Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation, AAPS PharmSciTech, 6, E158, 10.1208/pt060224

Ribeiro, 2008, Preparation of nanodispersions containing β-carotene by solvent displacement method, Food Hydrocoll, 22, 12, 10.1016/j.foodhyd.2007.04.009

Niwa, 1993, Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with d,l-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior, J Control Release, 25, 89, 10.1016/0168-3659(93)90097-O

Murakami, 1999, Preparation of poly(d,l-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method, Int J Pharm, 187, 143, 10.1016/S0378-5173(99)00187-8

Cui, 2006, Biodegradable nanoparticles loaded with insulin–phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation, J Control Release, 114, 242, 10.1016/j.jconrel.2006.05.013

Semo, 2007, Casein micelle as a natural nano-capsular vehicle for nutraceuticals, Food Hydrocoll, 21, 936, 10.1016/j.foodhyd.2006.09.006

Kipp, 2004, The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs, Int J Pharm, 284, 109, 10.1016/j.ijpharm.2004.07.019

Üner, 2006, Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems, Pharmazie, 61, 375

Müller, 2000, Solid lipid nanoparticles (SLN) for controlled drug delivery — a review of the state of the art, Eur J Pharm Biopharm, 50, 161, 10.1016/S0939-6411(00)00087-4

Runge S.A.F. (1998) Lipid-Nanopartikel (SLN) als kolloidaler Arzneistoffträger für Cyclosporin A, Ph.D. thesis, Free University of Berlin.

Ma, 2007, Preparation of tea polyphenols-loaded solid lipid nanoparticles based on the phase behaviors of hot microemulsions, Solid State Phenom, 121–123, 705, 10.4028/www.scientific.net/SSP.121-123.705

Kristl, 2003, Effect of colloidal carriers on ascorbyl palmitate stability, Eur J Pharm Sci, 19, 181, 10.1016/S0928-0987(03)00104-0

López-Quintela, 2003, Synthesis of nanomaterials in microemulsions: formation mechanisms and growth control, Curr Opin Colloid Interface Sci, 8, 137, 10.1016/S1359-0294(03)00019-0

Destrée, 2006, Mechanism of formation of inorganic and organic nanoparticles from microemulsions, Adv Colloid Interface Sci, 123–126, 353, 10.1016/j.cis.2006.05.022

Li, 2007, Technologies for preparation of nanomedicine, J Clin Rehabil Tissue Eng Res, 11, 2597

Pouton, 2000, Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying, and self-microemulsifying drug delivery systems, Eur J Pharm Sci, 11, S93, 10.1016/S0928-0987(00)00167-6

Porter, 2001, In vitro assessment of oral lipid based formulations, Adv Drug Deliv Rev, 50, S127, 10.1016/S0169-409X(01)00182-X

Cui, 2005, Self-microemulsifying drug delivery systems (SMEDDS) for improving in vitro dissolution and oral absorption of Pueraria lobata isoflavone, Drug Dev Ind Pharm, 31, 349, 10.1081/DDC-54309

Zhu, 2005, Synthesis of nanocapsules by complex coacervation in microemulsion, Acta Chimi Sin, 63, 1505

Lee, 2003, Microencapsulation of lipid nanoparticles containing lipophilic drug, J Microencapsul, 20, 489, 10.1080/0265204031000093032

Hernell, 1990, Physical–chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during uodenal fat digestion in healthy adult human beings, Biochemistry®, 2041, 10.1021/bi00460a012

Faulks, 2005, Challenges to understanding and measuring carotenoid bioavailability, Biochim Biophys Acta, 1740, 95, 10.1016/j.bbadis.2004.11.012

2003

Ball, 2006

Parker, 1996, Absorption, metabolism, and transport of carotenoids, FASEB J, 10, 542, 10.1096/fasebj.10.5.8621054

Johnson, 1996, Guidance in setting of drug particle size specifications to minimize variability in absorption, Pharm Res, 13, 1795, 10.1023/A:1016068705255

Oh, 1993, Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model, Pharm Res, 10, 264, 10.1023/A:1018947113238

Desai, 1996, Gastrointestinal uptake of biodegradable microparticles: effect of particle size, Pharm Res, 13, 1838, 10.1023/A:1016085108889

Hussain, 2001, Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics, Adv Drug Deliv Rev, 50, 107, 10.1016/S0169-409X(01)00152-1

Wu, 2004, The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human, Int J Pharm, 285, 135, 10.1016/j.ijpharm.2004.08.001

Luo, 2006, Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability, J Control Release, 114, 53, 10.1016/j.jconrel.2006.05.010

Jani, 1990, Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency, J Pharm Pharmacol., 42, 821, 10.1111/j.2042-7158.1990.tb07033.x

Jinno, 2006, Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs, J Control Release, 111, 56, 10.1016/j.jconrel.2005.11.013

des Rieux, 2006, Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach, J Control Release, 116, 1, 10.1016/j.jconrel.2006.08.013

Amidon, 1995, A theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res, 12, 413, 10.1023/A:1016212804288

Dubbs, 1998, Solubility of vitamin E (r-tocopherol) and vitamin K3 (Menadione) in ethanol–water mixture, J Chem Eng Data, 43, 590, 10.1021/je980017l

Kreuter, 1991, Peroral administration of nanoparticles, Adv Drug Deliv Rev, 7, 71, 10.1016/0169-409X(91)90048-H

Lai, 2007, Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus, Proc Natl Acad Sci USA, 104, 1482, 10.1073/pnas.0608611104

Delie, 1998, Evaluation of nano- and microparticle uptake by the gastrointestinal tract, Adv Drug Deliv Rev, 34, 221, 10.1016/S0169-409X(98)00041-6

Florence, 1997, The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual, Pharm Res, 14, 259, 10.1023/A:1012029517394

Nellans, 1991, Mechanisms of peptide and protein absorption. (1) Paracellular intestinal transport: modulation of absorption, Adv Drug Deliv Rev, 7, 339, 10.1016/0169-409X(91)90013-3

Clark, 2000, Lectin-mediated mucosal delivery of drugs and microparticles, Adv Drug Deliv Rev, 43, 207, 10.1016/S0169-409X(00)00070-3

Clark, 2001, Exploiting M cells for drug and vaccine delivery, Adv Drug Deliv Rev, 50, 81, 10.1016/S0169-409X(01)00149-1

Brayden, 2001, Oral vaccination in man using antigens in particles: current status, Eur J Pharm Sci, 14, 183, 10.1016/S0928-0987(01)00175-0

Biesa, 2004, Lectin-mediated drug targeting: history and applications, Adv Drug Deliv Rev, 56, 425, 10.1016/j.addr.2003.10.030

Ohno, 2006, Effect of lectins on the transport of food factors in Caco-2 cell monolayers, J Agric Food Chem, 54, 548, 10.1021/jf052040y

Takeuchi, 2001, Mucoadhesive nanoparticulate systems for peptide drug delivery, Adv Drug Deliv Rev, 47, 39, 10.1016/S0169-409X(00)00120-4

Qaqish, 1999, Synthesis of a fluorescent chitosan derivative and its application for the study of chitosan–mucin interactions, Carbohydr Polym, 38, 99, 10.1016/S0144-8617(98)00109-X

Norris, 1997, Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin, J Appl Polym Sci, 63, 1481, 10.1002/(SICI)1097-4628(19970314)63:11<1481::AID-APP10>3.0.CO;2-5

Yoncheva, 2005, Bioadhesive properties of pegylated nanoparticles, Expert Opin Drug Deliv, 2, 205, 10.1517/17425247.2.2.205

Lamprecht, 2006, Low molecular weight heparin nanoparticles: mucoadhesion and behaviour in Caco-2 cells, Nanotechnology, 17, 3673, 10.1088/0957-4484/17/15/009

Sakuma, 2002, Optimized chemical structure of nanoparticles as carriers for oral delivery of salmon calcitonin, Int J Pharm, 239, 185, 10.1016/S0378-5173(02)00113-8

Cui, 2002, Topical immunization using nanoengineered genetic vaccines, J Control Release, 81, 173, 10.1016/S0168-3659(02)00051-2

Reuben, 1984, Bile formation: sites and mechanisms, Hepatology, 4, 15S, 10.1002/hep.1840040804

Madsen, 1990, Intestinal absorption of bile salts, Can J Gastroenterol, 4, 79, 10.1155/1990/624985

Furr, 1997, Intestinal absorption and tissue distribution of carotenoids, J Nutr Biochem, 8, 364, 10.1016/S0955-2863(97)00060-0

Ratnam, 2006, Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective, J Control Release, 113, 189, 10.1016/j.jconrel.2006.04.015